Healthcare provider profile · identity verified

Gregory L Glance, M.D.

Internal Medicine · ASHEVILLE, NC · NPI 1386610632

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	857	249
Amlodipine Besylate	Amlodipine Besylate	516	147
Levothyroxine Sodium	Levothyroxine Sodium	505	149
Omeprazole	Omeprazole	425	131
Rosuvastatin Calcium	Rosuvastatin Calcium	371	113
Lisinopril	Lisinopril	352	101
Losartan Potassium	Losartan Potassium	320	100
Simvastatin	Simvastatin	289	84
Lorazepam	Lorazepam	282	50
Pantoprazole Sodium	Pantoprazole Sodium	267	79
Metoprolol Succinate	Metoprolol Succinate	248	73
Olmesartan Medoxomil	Olmesartan Medoxomil	229	58
Zolpidem Tartrate	Zolpidem Tartrate	229	49
Hydrochlorothiazide	Hydrochlorothiazide	204	63
Allopurinol	Allopurinol	199	58
Tamsulosin Hcl	Tamsulosin Hcl	199	66
Escitalopram Oxalate	Escitalopram Oxalate	195	57
Metformin Hcl	Metformin Hcl	192	56
Trazodone Hcl	Trazodone Hcl	190	52
Clonazepam	Clonazepam	178	23
Irbesartan	Irbesartan	169	46
Tramadol Hcl	Tramadol Hcl	167	28
Sertraline Hcl	Sertraline Hcl	165	47
Synthroid	Levothyroxine Sodium	161	40
Eliquis	Apixaban	155	43
Metoprolol Tartrate	Metoprolol Tartrate	154	43
Atenolol	Atenolol	153	42
Potassium Chloride	Potassium Chloride	152	40
Meloxicam	Meloxicam	151	52
Gabapentin	Gabapentin	148	48
Metformin Hcl Er	Metformin Hcl	147	48
Alprazolam	Alprazolam	143	26
Famotidine	Famotidine	124	43
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	113	35
Furosemide	Furosemide	108	34
Montelukast Sodium	Montelukast Sodium	101	29
Citalopram Hbr	Citalopram Hydrobromide	94	26
Glimepiride	Glimepiride	92	26
Fluticasone Propionate	Fluticasone Propionate	91	31
Bupropion Xl	Bupropion Hcl	84	21
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	84	19
Celecoxib	Celecoxib	83	31
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	81	21
Clopidogrel	Clopidogrel Bisulfate	80	23
Fluoxetine Hcl	Fluoxetine Hcl	80	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	24
Spironolactone	Spironolactone	78	27
Valsartan	Valsartan	78	24
Carvedilol	Carvedilol	73	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	22
Albuterol Sulfate Hfa	Albuterol Sulfate	71	26
Jardiance	Empagliflozin	70	17
Ozempic	Semaglutide	70	13
Pravastatin Sodium	Pravastatin Sodium	63	22
Xarelto	Rivaroxaban	61	15
Pioglitazone Hcl	Pioglitazone Hcl	59	16
Estradiol	Estradiol	57	17
Pregabalin	Pregabalin	57	15
Diazepam	Diazepam	56	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	54	15
Duloxetine Hcl	Duloxetine Hcl	53	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	13
Paroxetine Hcl	Paroxetine Hcl	51	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	49	14
Premarin	Estrogens, Conjugated	49	13
Valacyclovir	Valacyclovir Hcl	49	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	15
Warfarin Sodium	Warfarin Sodium	46	suppressed
Benazepril Hcl	Benazepril Hcl	44	12
Chlorthalidone	Chlorthalidone	42	suppressed
Mounjaro	Tirzepatide	40	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	37	12
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Finasteride	Finasteride	36	12
Ezetimibe	Ezetimibe	34	13
Lovastatin	Lovastatin	34	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Novolog Flexpen	Insulin Aspart	28	suppressed
Eszopiclone	Eszopiclone	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Carisoprodol	Carisoprodol	26	suppressed
Cefdinir	Cefdinir	26	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Nitroglycerin	Nitroglycerin	26	16
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	25	19
Synjardy Xr	Empagliflozin/Metformin Hcl	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Linzess	Linaclotide	23	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	23	suppressed
Prednisone	Prednisone	22	16
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Dilt-Xr	Diltiazem Hcl	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Tiadylt Er	Diltiazem Hcl	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	17	17
Humalog Kwikpen U-200	Insulin Lispro	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Baclofen	Baclofen	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Glipizide	Glipizide	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Glyxambi	Empagliflozin/Linagliptin	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Temazepam	Temazepam	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Indapamide	Indapamide	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error